Baxter International Inc. Share Price Sao Paulo

Equities

B1AX34

BRB1AXBDR004

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 20:54:31 27/05/2024 BST 5-day change 1st Jan Change
88.65 BRL -17.00% Intraday chart for Baxter International Inc. -0.30% -6.53%

Financials

Sales 2024 * 15.11B 78.17B 1,182B Sales 2025 * 15.66B 81B 1,225B Capitalization 17.27B 89.36B 1,352B
Net income 2024 * 703M 3.64B 55.01B Net income 2025 * 950M 4.91B 74.34B EV / Sales 2024 * 1.79 x
Net Debt 2024 * 9.7B 50.2B 759B Net Debt 2025 * 8.8B 45.52B 689B EV / Sales 2025 * 1.67 x
P/E ratio 2024 *
18.4 x
P/E ratio 2025 *
15.1 x
Employees 60,000
Yield 2024 *
3.52%
Yield 2025 *
3.65%
Free-Float 74.27%
More Fundamentals * Assessed data
Dynamic Chart
1 day-17.00%
1 week-0.30%
Current month-13.26%
1 month-4.79%
3 months-19.25%
6 months+0.92%
Current year-6.53%
More quotes
1 week
86.70
Extreme 86.7
89.10
1 month
86.70
Extreme 86.7
100.00
Current year
86.70
Extreme 86.7
109.78
1 year
80.00
Extreme 80
119.74
3 years
80.00
Extreme 80
253.25
5 years
80.00
Extreme 80
263.70
10 years
80.00
Extreme 80
263.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 30/09/15
Director of Finance/CFO 54 17/10/23
Chief Tech/Sci/R&D Officer - 31/12/16
Members of the board TitleAgeSince
Director/Board Member 73 05/02/17
Director/Board Member 64 09/05/22
Director/Board Member 64 17/02/19
More insiders
Date Price Change Volume
27/05/24 88.65 +0.51% 1
24/05/24 88.2 +0.36% 1
23/05/24 87.88 -1.37% 2
22/05/24 89.1 +0.20% 1

Delayed Quote Sao Paulo, May 27, 2024 at 08:54 pm

More quotes
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
33.9 USD
Average target price
46.07 USD
Spread / Average Target
+35.89%
Consensus